A detailed history of Amussen Hunsaker Associates LLC transactions in Pfizer Inc stock. As of the latest transaction made, Amussen Hunsaker Associates LLC holds 12,759 shares of PFE stock, worth $355,082. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,759
Previous 12,749 0.08%
Holding current value
$355,082
Previous $367,000 3.54%
% of portfolio
0.06%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $258 - $297
10 Added 0.08%
12,759 $354,000
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $1,175 - $1,527
-45 Reduced 0.35%
12,749 $367,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $224 - $262
7 Added 0.05%
12,794 $424,000
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $7,007 - $8,107
-194 Reduced 1.49%
12,787 $469,000
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $275 - $358
7 Added 0.05%
12,981 $529,000
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $60,788 - $79,352
-1,456 Reduced 10.09%
12,974 $665,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $19,298 - $23,558
-441 Reduced 2.97%
14,430 $708,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $95,479 - $113,208
-2,052 Reduced 12.13%
14,871 $778,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $278,526 - $345,128
-6,088 Reduced 26.46%
16,923 $873,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $15,618 - $23,152
378 Added 1.67%
23,011 $1.27 Million
Q3 2021

Nov 16, 2021

BUY
$39.25 - $50.42 $9,655 - $12,403
246 Added 1.1%
22,633 $965,000
Q2 2021

Aug 17, 2021

SELL
$35.91 - $40.68 $18,242 - $20,665
-508 Reduced 2.22%
22,387 $876,000
Q1 2021

May 18, 2021

BUY
$33.49 - $37.77 $23,878 - $26,930
713 Added 3.21%
22,895 $829,000
Q4 2020

Feb 17, 2021

BUY
$33.47 - $42.56 $34,440 - $43,794
1,029 Added 4.86%
22,182 $816,000
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $222,821 - $261,420
7,018 Added 49.65%
21,153 $752,000
Q2 2020

Aug 17, 2020

SELL
$30.12 - $36.54 $18,614 - $22,581
-618 Reduced 4.19%
14,135 $494,000
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $12,298 - $17,572
-455 Reduced 2.99%
14,753 $456,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $296 - $336
9 Added 0.06%
15,208 $596,000
Q3 2019

Nov 15, 2019

BUY
$32.49 - $42.13 $288,186 - $373,693
8,870 Added 140.15%
15,199 $546,000
Q2 2019

Aug 20, 2019

SELL
$36.98 - $41.52 $327,346 - $367,535
-8,852 Reduced 58.31%
6,329 $274,000
Q1 2019

May 16, 2019

BUY
$37.5 - $41.2 $39,900 - $43,836
1,064 Added 7.54%
15,181 $639,000
Q4 2018

Feb 19, 2019

BUY
$38.47 - $43.86 $37,892 - $43,202
985 Added 7.5%
14,117 $616,000
Q3 2018

Nov 16, 2018

BUY
$34.47 - $41.81 $82,245 - $99,758
2,386 Added 22.2%
13,132 $579,000
Q2 2018

Aug 16, 2018

BUY
$32.98 - $35.16 $62,200 - $66,311
1,886 Added 21.29%
10,746 $390,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $3,510 - $4,072
110 Added 1.26%
8,860 $314,000
Q4 2017

Feb 16, 2018

SELL
$33.26 - $35.29 $21,885 - $23,220
-658 Reduced 6.99%
8,750 $317,000
Q3 2017

Nov 15, 2017

BUY
$31.0 - $34.15 $291,648 - $321,283
9,408
9,408 $336,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Amussen Hunsaker Associates LLC Portfolio

Follow Amussen Hunsaker Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.